MRMD News and Press, MariMed Inc From 08/06/25

Sera Prognostics Inc. (SERA) is expected to report $-0.21 for Q2 2025 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.51 for Q2 2025 Context Therapeutics Inc. (CNTX) is expected to report $-0.06 for Q2 2025 Genco Shipping & Trading ...

MariMed Inc (MRMD) is expected to report $-0.01 for Q2 2025

2025-08-05 13:57:31 ET More on MariMed MariMed Inc. (MRMD) Q1 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on MariMed Historical earnings data for MariMed Financial information for MariMed Read the full article o...

NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a strategic agreement with TILT Holdings (“TILT”) (CBOE: ...

2025-07-29 11:19:30 ET More on Tilray Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript Tilray Q4 Results Show Major Problems Why I Am Downgrading Tilray Brands Tilray outlines $62M-$72M adjusted EBITDA guidance for 2026 amid international cannabis ...

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”), a vertically integrated cannabis operator in Maine. ...

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”), a vertically integrated cannabis operator in Maine. ...

NORWOOD, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report second quarter 2025 financial results on August 6, 20...

NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Following today’s announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We are excited to participate in the expansion of Delaware’s cannabis progra...

NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage ™, continued to drive innovation with the launch of MycroDose by Nature...